Frontiers in Oncology Seminars
Immunotherapy for Brain Tumors
Michael Lim, MD
Tuesday, September 15, 2020
Dr. Michael Lim is Professor and Chair of Neurosurgery at Stanford University School of Medicine. Dr. Lim obtained his medical degree from the Johns Hopkins University School of Medicine. He then completed his residency in Neurosurgery at Stanford and went on to become a Professor of Neurosurgery, Oncology and Radiation Oncology at Johns Hopkins before returning to Stanford. Dr. Lim’s surgical interest is in both benign and malignant brain tumors, with a particular interest in gliomas (including ependymoma), meningioma, pituitary tumors and skull base tumors. He has extensive experience in new and innovative neurosurgical techniques including image guided surgery, microsurgery, minimally invasive procedures and endoscopic surgery.
Dr. Lim’s primary research interest is developing immune-based therapies against brain tumors. His research laboratory is focused on understanding the mechanisms of immune evasion by primary brain tumors. Findings from his laboratory are directed towards translation to novel therapies against brain tumors. He currently serves as the principal investigator of several large brain tumor immunotherapy clinical trials based on findings from his laboratory.